Ritonavir is a medication used in the treatment of HIV (human immunodeficiency virus) infection. Ritonavir is classified as a protease inhibitor, a type of medication that functions by inhibiting the activity of the HIV protease enzyme. By inhibiting this enzyme, ritonavir helps to prevent the replication of the virus and slow down the progression of HIV disease.

In combination with other antiretroviral drugs, ritonavir is used as part of highly active antiretroviral therapy (HAART) to suppress viral replication, reduce the viral load in the body, and improve immune function. It is effective in both treatment-naïve individuals and those who have developed resistance to other antiretroviral medications.


Ritonavir is also used as a boosting agent in combination with certain other protease inhibitors. When used in this way, ritonavir helps to increase the concentration and effectiveness of the co-administered protease inhibitor, enhancing its antiviral activity.

Apart from its use in HIV treatment, ritonavir has also been utilized in the treatment of hepatitis C and as a pharmacokinetic enhancer for other medications, improving their bioavailability and prolonging their action in the body.


It is important to note that ritonavir is not a standalone treatment for HIV and should always be used in combination with other antiretroviral drugs. Like other medications, ritonavir can cause side effects, including gastrointestinal issues, changes in blood lipid levels, and interactions with other drugs. Therefore, it should be taken under the guidance of a healthcare professional who can monitor its effectiveness and manage any potential side effects.

In summary, ritonavir is a protease inhibitor used in the treatment of HIV infection as part of combination therapy. It helps suppress viral replication, reduce viral load, and improve immune function. Additionally, ritonavir acts as a boosting agent and has applications in hepatitis C treatment and enhancing the pharmacokinetics of other medications.